The frequency of intratubular embryonal carcinoma: Implications for the pathogenesis of germ cell tumours

Histopathology

Volumn 45, Issue 2, 2004, Pages 155-161

  Berney, D M ^a   Lee, A ^a   Randle, S J ^a   Jordan, S ^a   Shamash, J ^a   Oliver, R T D ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

CD30; Germ cell tumour; Intratubular embryonal carcinoma

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; CD30 ANTIGEN;

ARTICLE; CELLULAR DISTRIBUTION; DISEASE COURSE; EMBRYONAL CARCINOMA; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MORBIDITY; NON SEMINOMATOUS GERMINOMA; PATHOGENESIS; PRIORITY JOURNAL; SEMINOMA;

ANTIGENS, CD30; CARCINOMA, EMBRYONAL; GERMINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; SEMINIFEROUS TUBULES; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 4344658541     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01915.x     Document Type: Article

References (32)

1. Skakkebaek NE. Possible carcinoma-in-situ of the undescended testis. Lancet 1972; 2; 516-517.
2. Skakkebaek NE. Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 1978; 2; 157-170.
3. Jacobson GK, Barlebo H, Olsen J et al. Testicular germ cell tumours in Denmark 1976-1980: pathology of 1058 consecutive cases. Acta Radiol. Oncol. 1984; 23; 239-247.
4. Akhtar M, Sidiki Y. Undifferentiated intratubular germ cell tumour of the testis: light and electron microscope study of a unique case. Cancer 1979; 43; 2332-2339.
5. Mostofi FK, Sesterhenn IA. Pathology of germ cell tumors of the testes. Prog. Clin. Biol. Res. 1985; 203; 1-34.
6. Ulbright TM, Amin MB, Young RH. Tumors of the testis, adenexa, spermatic cord and scrotum. In Rosai J ed. Atlas of tumor pathology. Washington: AFIP, 1999; 25; 41-58.
7. Oosterhuis JW, Gillis AJ, van Putten WJ, de Jong B, Looijenga LH. Interphase cytogenetics of carcinoma in situ of the testis. Numeric analysis of the chromosomes 1, 12 and 15. Eur. Urol. 1993; 23; 16-21.
8. De Graaf WE, Oosterhuis JW, de Jong B et al. Ploidy of testicular carcinoma in situ. Lab. Invest. 1992; 66; 166-168.
9. De Jong B, Oosterhuis JW, Castedo SM, Vos A, te Meerman GJ. Pathogenesis of adult testicular germ cell tumours. A cytogenetic model. Cancer Genet. Cytogenet. 1990; 48; 143-167.
10. Delahunt B, Mostofi FK, Sesterhenn IA, Ribas JL, Avallone FA. Nucleolar organizer regions in seminoma and intratubular malignant germ cells. Mod. Pathol. 1990; 3; 141-145.
11. van Echten J, van Gurp RJ, Stoepker M, Looijenga LH, de Jong J, Oosterhuis W. Cytogenetic evidence that carcinoma in situ is the precursor lesion for invasive testicular germ cell tumours. Cancer Genet. Cytogenet. 1995; 85; 133-137.
12. Srigley JR, Mackay B, Toth P, Ayala A. The ultrastructure and histogenesis of male germ cell neoplasia with emphasis on seminoma with early carcinomatous features. Ultrastruc. Pathol. 1988; 12; 67-86.
13. Burke AP, Mostofi FK. Intratubular malignant germ cells in testicular biopsies: clinical course and identification by staining for placental alkaline phosphatase. Mod. Pathol. 1988; 1; 475-479.
14. Izquierdo MA, Van der Valk P, Van Ark-Otte J et al. Differential expression of the c-kit proto-oncogene in germ cell tumours. J. Pathol. 1995; 177; 253-258.
15. Strohmeyer T, Reese D, Press M, Ackermann R, Hartmann M, Slamon D. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J. Urol. 1995; 153; 511-515.
16. Ferreiro JA. Ber-H2 expression in testicular germ cell tumours. Hum. Pathol. 1994; 25; 522-524.
17. Pallesen G, Hamilton-Dutoit SJ. Ki-1 (CD30) antigen is regularly expressed by tumour cells of embryonal carcinoma. Am. J. Pathol. 1988; 133; 446-450.
18. Rohde D, Hansen H, Hafner M et al. Cellular localizations and processing of two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen: the protein kinase Ki-1/57 occurs in the nucleus. Am. J. Pathol. 1992; 140; 473-482.
19. Schwab H, Syein H, Gerdes J et al. Production of a monoclonal antibody specific for Hodgkins and Reed-Sternberg cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299; 65-67.
20. Stein H, Mason DY, Gerdes J et al. The expression of Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sterberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66; 848-858.
21. Durkop H, Fiss H-D, Eitelbach F et al. Expression of the CD30 antigen in non-lymphoid tissues and cells. J. Pathol. 2000; 190; 613-618.
22. Latza U, Foss H-D, Durkop H et al. CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule. Am. J. Pathol. 1995; 140; 463-471.
23. Hittmair A, Rogatch H, Hobisch A, Mikuz G, Feichtinger H. CD30 expression in seminoma. Hum. Pathol. 1996; 27; 1166-1171.
24. Berney DM, Shamash J, Pieroni K, Oliver RTD. Loss of CD30 expression in metastatic embryonal carcinoma: an effect of chemotherapy? Histopathology 2001; 39; 382-385.
25. Smith CA, Gruss HJ, Davis T et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73; 1349-1360.
26. Bowen MA, Olsen KJ, Cheng L, Avila D, Podack ER. Functional effects of CD30 on a large granular cell lymphoma cell line,YT. J. Immunol. 1993; 151; 5896-5906.
27. Pera MF, Bennett W, Cerretti DP. CD30 and its ligand: possible role in regulation of teratoma stem cells. APMIS 1998; 106; 169-173.
28. Rakheja D, Hoang MP, Sharma S, Albores-Saavedra J. Intratubular embryonal carcinoma. Arch. Pathol. Lab. Med. 2002; 126; 487-490.
29. Pierce GB Jr, Abell MR. Embryonal carcinoma of the testis. Pathol. Annu. 1970; 4; 27-60.
30. Bredael JJ, Vugrin D, Whitmore WF Jr. Autopsy findings in 154 patients with germ cell tumours of the testis. Cancer 1982; 50; 548-551.
31. Czaja JT, Ulbright TM. Evidence for transformation of seminoma to yolk sac tumour with histogenetic considerations. Am. J. Clin. Pathol. 1992; 97; 468-477.
32. Rajpert-De Meyts E, Kvist M, Skakkebaek NE. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance. Virchows Arch. 1996; 428; 133-139.